CATALIN

Dose: 750 to 1500 ug
Single Dose: 1100 (1125)
Frequency: 4.8 hourly
Route: Ophthalmic
Instructions:

belongs to Pyrido Phenoxazine. It belongs to Opthalmic Products and Anticataract pharmacological group.The Molecular Weight of Pirenoxine is 3302.00.

Pirenoxine is contraindicated in conditions like Placenta previa,Uterine hyperactivity.

The severe or irreversible adverse effects of Pirenoxine, which give rise to further complications include Keratitis, Marginalis, Conjunctival infections, Smarting.The symptomatic adverse reactions produced by Pirenoxine are more or less tolerable and if they become severe, they can be treated symptomatically, these include Itching, Blepharitis.

Pirenoxine is primarily indicated in conditions like Cataract, Induction of labour, Inevitable abortion, Labor augmentation, Lactation induction, Postpartum haemorrhage, Uterine atonia.

No data regarding the interactions of Pirenoxine was found.

If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Eye drops

Use only by instillation, store the ophthalmic solution, once prepared, protects from heat, light and moisture and use within 20 days. Avoid contact of the tip of dropper with eye when instilling. This drug changes colour in the presence of metallic ion.